The Action Mechanism of the Purified Platelet Aggregation Principle of Trimeresurus mucrosquamatus Venom

Chaoho Ouyang; Che-Ming Teng

doi:10.1055/s-0038-1646800

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1979; 41(03): 475-490
DOI: 10.1055/s-0038-1646800

Original Articles

Schattauer GmbH Stuttgart

The Action Mechanism of the Purified Platelet Aggregation Principle of Trimeresurus mucrosquamatus Venom

Authors

Chaoho Ouyang

The Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China
Che-Ming Teng

The Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China

Abstract

als PDF herunterladen

Summary

The minimal concentration of the platelet aggregation principle (Platelet Aggregoserpen- tin, PAS) necessary to induce platelet aggregation was 10 ng/ml, about one-hundredth of that of the crude venom. PAS induced the release of platelet factors 3 and 4 from platelets, but the released platelet factor 3 was easily inactivated by the anti-phospholipid effect of PAS. Pretreatment of platelets with neuraminidase potentiated PAS-induced platelet aggregation. PAS-induced platelet aggregation was independent on released ADP; it could occur in the ADP-removing systems, such as apyrase or a combination of phosphoenolpyruvate and pyruvate kinase. However, PAS-induced platelet aggregation could be inhibited by adenine nucleotides and adenosine.

PAS-induced platelet aggregation was inhibited by some anti-inflammatory agents, antimalarial drugs, local anesthetics, antihistamine and smooth muscle relaxants. After deaggregation of PAS-treated platelets, thrombin and sodium arachidonate could further induce platelet aggregation, but ADP and second dose of PAS could not. It is concluded that PAS-induced platelet aggregation is due to prostaglandin synthesis. Recent literatures on the mechanism of platelet aggregation were surveyed and the actions of PAS were discussed.

PDF (1813 kb)

Referenzen

References
1 Aledort LM, Niemetz J. 1968; Dissociation of platelet aggregation from clot retraction, potassium loss, and adenosine triphosphatase activity. Proceedings of the Society for Experimental Biology and Medicine 128: 658
2 Ardlie NG, Glew G, Schultz BG, Schwartz CJ. 1967; Inhibition and reversal of platelet aggregation by methylxanthines. Thrombosis et Diathesis Haemorrhagica 18: 670
3 Ardlie NG, Perry DW, Packham MA, Mustard JF. 1971; Influence of apyrase on stability of suspensions of washed rabbit platelets. Proceedings of the Society for Experimental Biology and Medicine 136: 1021
4 Biran H, Dvilansky A, Nathan I, Live A. 1974; Impairement of human platelet aggregation and serotonin release caused in vitro by Echis colorata venom. Thrombosis et Diathesis Haemorrhagica 30: 191
5 Boffa MC, Boffa GA. 1974 Correlations between the enzymatic and factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochimica et Biophysica Acta.
6 Boffa MC, Delori P, Soulier JP. 1972; Anticoagulant factors from Viperidae venoms. Platelet phospholipid inhibitors. Thrombosis et Diathesis Haemorrhagica 28: 509
7 Bond GH, Hudgins PM. 1976; Inhibition of ATPase activity in human red cell membranes by tetracaine. Biochemical Pharmacology 25: 267
8 Born GV R, Cross MJ. 1963; The aggregation of blood platelet. Journal of Physiology 168: 178
9 Bradlow BA, Marcus AJ. 1966; Action of snake venom phospholipase A on isolated platelet membranes. Proceedings of the Society for Experimental Biology and Medicine 123: 889
10 Cohen P, Derksen A. 1969; Comparison of phospholipid and fatty acid composition of human erythrocytes and platelets. British Journal of Haematology 17: 359
11 Condrea E, De Vries A, Mayer J. 1962; Action of snake venom phospholipase A on free and lipoprotein-bound phospholipids. Biochimica et Biophysica Acta 58: 389
12 Davey MG, Lüscher EF. 1965; Action of some coagulant snake venoms upon blood platelets. Nature (London) 207: 1037
13 Davey MG, Luscher EF. 1967; Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature (London) 216: 857
14 Davis JW, Yue KT N, Phillips PE. 1972; The effect of neuraminidase on platelet aggregation induced by ADP, norepinephrine, collagen or serotonin. Thrombosis et Diathesis Haemorrhagica 28: 221
15 Day HJ, Holmsen H, Zucker MB. 1975; Methods for separating platelets from blood and plasma. Thrombosis et Diathesis Haemorrhagica 33: 648
16 Derksen A, Cohen P. 1975; Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. Journal of Biological Chemistry 250: 9342
17 Didisheim P, Kazmier FJ, Fuster V. 1974; Platelet inhibition in the management of thrombosis. Thrombosis et Diathesis Haemorrhagica 32: 21
18 Feinstein M, Fiekers J, Fraser C. 1976; An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion. Journal of Pharmacology and Experimental Therapeutics 197: 215
19 Flower RJ, Blackwell GJ. 1976; The importance of phospholipase A₂ in prostaglandin biosynthesis. Biochemical Pharmacology 25: 285
20 Greenberg J, Packham MA, Cazenave JP, Reimers HJ, Mustard JF. 1975; Effects on platelet function of removal of platelet sialic acid by neuraminidase. Laboratory Investigations 32: 476
21 Hamberg M, Svensson J, Samuelsson B. 1975; Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Sciences 72: 2994
22 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. 1974; a Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proceedings of the National Academy of Sciences 71: 345
23 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. 1974; b Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proceedings of the National Academy of Sciences 71: 3400
24 Hampton J. 1971; Trends in the development of antithrombotic agents. American Journal of Cardiology 27: 659
25 Harbury CB, Hershagold JE, Schrier SL. 1972; Requirements for aggregation of washed human platelets suspended in buffered salt solutions. Thrombosis et Diathesis Haemorrhagica 28: 2
26 Haslam RJ. 1964; Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature 202: 765
27 Haslam RJ. 1973; Interactions of the pharmacological receptors of blood platelets with adenyl cyclase. Seminar Haematologica 6: 333
28 Haslam RJ, Lynham JA. 1972; Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine. Life Science 11: 1143
29 HIRSH J, GENT M, GENTON E. 1975; The current status of platelet suppressive drugs in the treatment of thrombosis. Thrombosis et Diathesis Haemorrhagica 33: 406
30 Hovig T. 1963; Aggregation of rabbit blood platelets produced in vitro by “saline extract” of tendons. Thrombosis et Diathesis Haemorrhagica 9: 248
31 Jesse RL, Cohen P. 1976; Arachidonic acid release from diacyl phosphatidylethanolamine by human platelet membranes. Biochemical Journal 158: 283
32 Kazimierczak W, Peret M, Máslínski C. 1976; The action of local anesthetics on histamine release. Biochemical Pharmacology 25: 1747
33 Kirschmann C, Aloof S, De Vries A. 1963; Action of lysolecithin on blood platelets. Thrombosis et Diathesis Haemorrhagica 9: 512
34 Kirschmann C, Condrea E, Moau N. 1964; Action of snake venom on human platelet phospholipids. Archives of the International Pharmacodyn 150: 372
35 Kolata GB. 1975; Thromboxanes: The power behind the prostaglandins. Science 190 770: 812
36 Leone G, Boni P, Vinceti A. 1976; Platelet aggregation by thimerosal, role of ADP and SH groups. Thrombosis and Haemostasis 35: 249
37 Macfarlane DE, Mills DC B. 1975; The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood 46: 309
38 Macmillan DC. 1966; Secondary clumping effect in human citrated platelet-rich plasma produced by ADP and adrenaline. Nature (London) 211: 140
39 Markus HB, Ball EG. 1969; Inhibition of lypolytic process in rat diphose tissue by antimalarial drugs. Biochimica et Biophysica Acta 187: 486
40 Markwardt F, Barthel W, Glusa E, Hoffmann A. 1966; N-S Archives of Experimental Pathology. Pharmacology 252: 297
41 Markwardt F, Hoffmann A. 1970; Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets. Biochemical Pharmacology 19: 2519
42 Marney SR. 1971; Platelet aggregation in heparinized plasma and citrated plasma. Relationship to ADP and inhibition by cobra factor. Journal of Immunology 106: 82
43 Mcnicol GP, Mitchell JR A, Reuter H, Van De Loo J. 1970; Platelet in thrombosis, their clinical significance and the evaluation of potential drugs. Thrombosis et Diathesis Haemorrhagica 31: 379
44 Meyer CJ, Van Breemen C, Casteels R. 1972; The action of Lanthanum and D600 on the calcium exchange in the smooth muscle cells of the guinea-pig taenia coli. Pflueeers Archives 337 333
45 Michel H, Caen JP, Born GV R, Miller R, Auriac GA, Meyer P. 1976; Relation between the inhibition of aggregation and the concentration of c-AMP in human and rat platelets. British Journal of Haematology 33: 27
46 Mustard JF, Perry DW, Ardlie NG, Packham MA. 1972; Preparation of suspensions of washed platelets from humans. British Journal of Haematology 22: 193
47 Nye SW, Graham JB, Brinkhous KM. 1962; The partial thromboplastin time as a screening test for the detection of latent bleeders. American Journal of Medical Science 243: 279
48 O’Brien JR. 1962; Platelet aggregation. II. Some results from a new method of study. Journal of Clinical Pathology 15: 452
49 Ouyang C, Teng CM. 1977 Purification and characterization of the platelet aggregation principle of Trimeresurus mucrosquamatus venom. Submitted for publication in Biochimica et Biophysica Acta.
50 Packham MA, Warrior ES, Glynn MF, Senyi AS, Mustard JF. 1967; Alternation of the response of platelet to surface stimuli by pyrazole compounds. Journal of Experimental Medicine 126: 171
51 Patscheke H, Brossmer R. 1975; Concanavalin A-induced aggregation of human blood platelets. Ca⁺⁺-dependent and Ca⁺⁺-independent effects. Thrombosis et Diathesis Haemorrhagica 33: 354
52 Praga CA, Pogliani EM. 1973; Effect of temperature on ADP-induced platelet aggregation. Thrombosis et Diathesis Haemorrhagica 29: 183
53 Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF. 1976; In vitro and in vivo functions of thrombin-treated platelets. Thrombosis et Diathesis Haemorrhagica 35: 151
54 Roth GJ, Majerus PW. 1975; The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particular fraction protein. Journal of Clinical Investigation 56: 624
55 Salzman EW, Levine L. 1971; Cyclic 3’,5’-adenosine monophosphate in human blood platelets. II. Effect of N⁶-2’-0-dibutyryl cyclic 3’,5’-adenosine monophosphate on platelet function. Journal of Clinical Investigation 50: 131
56 Samuelsson B, Granström E, Green K, Hamberg M, Hammarström S. 1975; Annual Review of Biochemistry. 44: 669
57 Saxon A, Kattlove HE. 1976; Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor. Blood 47. 951
58 Shtacher G, Crowley HJ, Dolton C. 1976; Inhibition of platelet aggregation by papaverinelike drugs: evidence for a novel mechanism of action. Biochemical Pharmacology 25: 1045
59 Simard-Duquesne N. 1973; Enhancement by ADP of thrombin-induced aggregation in ADP- refractory platelets. Thrombosis et Diathesis Haemorrhagica 29: 445
60 Sket D, Gubensek F. 1976; Pharmacological study of phospholipase A from Vipera ammodytes venom. Toxicon 14: 393
61 Strong PN, Goerke J, Oberg G, Kelly RB. 1976; P-Bungarotoxin, a pre-synaptic toxin with enzymatic activity. Proceedings of the National Academy of Sciences USA 73: 178
62 Thomson D, Forbes CD, Prentice CR M. 1973; A comparison of the effects of antihistamines on platelet function. Thrombosis et Diathesis Haemorrhagica 30: 547
63 Ungaro PC, Beck TM, Mccaa WM, Hershagold EJ. 1973; The in vivo and in vitro effect of antihistamines on platelet aggregation. Thrombosis et Diathesis Haemorrhagica 30: 597
64 Vane JR. 1971; Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biology) 231: 232
65 Vargaftic BB, Hai ND. 1972; Selective inhibition by mepacrine of the release of »rabbit aorta contracting substance« evoked by the administration of bradykinin. Journal of Pharmacy and Pharmacology 24: 159
66 Verhaeghe RH, Shepherd JT. 1976; Effect of nitroprusside on smooth muscle and adrenergic nerve terminals in isolated blood vessels. Journal of Pharmacology Experimental Therapeutics 199: 269
67 Warlow C, Corina A, Ogston D, Douglas AS. 1974; The relationship between platelet aggregation and time interval after venepuncture. Thrombosis and Diathesis Haemorrhagica 31: 133
68 WEISS HJ. 1976; Antiplatelet drugs - A new pharmacologic approach to the prevention of thrombosis. American Heart Journal 92: 86
69 Yue KT N, Davis JW, Aldridge EG. 1973; Effect of aspirin and benadryl on human platelet oxidative phosphorylation and aggregation. Thrombosis et Diathesis Haemorrhagica 30: 577
70 Zucker MB, Peterson J. 1968; Inhibition of adenosine diphosphate induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proceedings of the Society of Experimental Biology and Medicine 127: 547